Target intelligence / Profile preview

Herpes simplex virus helicase-primase subunit UL5 (UL5)

Target
UL5
Molecular classification
Enzyme, Helicase, Superfamily 1 helicase, P-loop NTPase
01

Overview

Herpes simplex virus helicase-primase subunit UL5 is an essential enzymatic component of the heterotrimeric helicase-primase complex (UL5/UL8/UL52) required for viral DNA replication (UniProt P04292). As a member of the Superfamily 1 (SF1) helicases, UL5 contains seven conserved motifs that facilitate ATP- or GTP-driven unwinding of double-stranded DNA in a 5' to 3' direction at the replication fork (PubMed 1561924). It works in close coordination with the UL52 primase subunit, which synthesizes RNA primers, and the UL8 scaffold protein, which coordinates the complex's activities and facilitates nuclear localization (PubMed 21613589). UL5 is a primary target for a novel class of non-nucleoside antivirals known as helicase-primase inhibitors (HPIs), including pritelivir and amenamevir (PubMed 34353927). These drugs bind to the UL5 subunit to inhibit DNA unwinding and primer synthesis, effectively halting viral genome duplication. Because HPIs do not require activation by viral thymidine kinase, they remain potent against acyclovir-resistant strains, making UL5 a critical target for treating refractory herpes simplex and varicella-zoster virus infections (PubMed 28838958).

Other names
UL5Helicase-primase helicase subunitDNA helicase-primase complex subunit UL5HSV-1 UL5HSV-2 UL5
02

Mechanism of action

Helicase-primase inhibition

03

Biological functions

DNA replicationDNA unwindingATP hydrolysisGTP hydrolysisRNA primer synthesisReplication fork progression
04

Disease associations

Infection
05

Safety considerations

Development of antiviral resistanceThrombocytopeniaGingival bleedingPalpitations
06

Interacting drugs

Pritelivir

4 more in the full profile.

07

Biomarkers

UL5 resistance mutationsViral DNA load

Beyond the preview

Go deeper on Herpes simplex virus helicase-primase subunit UL5 (UL5).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Herpes simplex virus helicase-primase subunit UL5 (UL5).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call